Blog

TOP 10 GU Oncology clinical papers/published trials by 2023 by Toni Choueiri

Photo of Toni K. Choueiri taken from old-prod.asco.org

Dec 31, 2023, 06:19

TOP 10 GU Oncology clinical papers/published trials by 2023 by Toni Choueiri

shared on LinkedIn:

“It is this time of the year again: TOP 10 GU Oncology clinical papers/published trials by 2023: Some negative, some positive, but we learned from all! Feel free to add more and retweet and tag This is not an exhaustive list!”

Additional information.
Source: /LinkedIn

Toni K. Choueiri is the Director of the Lank Center for Genitourinary (GU) Oncology at Dana-Farber Cancer Institute (DFCI), co-leader of the Kidney Cancer Program at Dana-Farber/Harvard Cancer Center, and the Jerome and Nancy Kohlberg Chair and Professor of Medicine at Harvard Medical School. He is the Medical Director of International Strategic Initiatives at Dana-Farber and past President of the Medical Staff at DFCI (2016-2018).

He received the George Canellos Award for Excellence in Clinical Investigation and Patient Care from DFCI in 2013, the Eugene Schonfeld Award from the Kidney Cancer Association (KCA) in 2016, and is a 2021 Giants of Cancer Care inductee. He serves on the National Comprehensive Cancer Network (NCCN) Kidney Cancer Panel, KidneyCan Board, the National Cancer Institute (NCI) GU Steering Committee, and is past Chairman (2015-2018) of the Medical and Scientific Steering Committee of the KCA.

Dr. Choueiri is an elected member of the American Society of Clinical Investigation (ASCI). In addition, he is an Aresty Scholar from the Wharton School of Business at the University of Pennsylvania.